Clinical Trials Logo
  1. Home
  2. Late-Onset Neonatal Sepsis
  3. NCT04424667

Clinical Impact of Donor Milk Pasteurized by HTST Treatment in Preterm Infants

Late-Onset Neonatal Sepsis Clinical Trial

Official title:
Clinical and Economic Impact of Supplementation With Donor Milk Pasteurized by HTST Method Versus Holder Method in Extremely Birth Weight Preterm Infants. Randomized Clinical Trial

Clinical Trial Summary

Randomized double-blind clinical trial to compare the incidence of microbiological proven late onset sepsis in extremely preterm infants (<1000 grams) that are supplemented with donor milk pasteurized by High Temperature Short Time (HTST) method versus the Holder method.

Clinical Trial Description

Donor milk pasteurized by an innovative High Temperature Short Time (HTST) system (patented by researchers) retains more immune and trophic compounds than pasteurized milk by traditional Holder method. These compounds are related to the protection conferred by breast milk against nosocomial sepsis and necrotizing enterocolitis in preterm infants, so it would be of interest to study if there is a clinical benefit in these patients when health professionals are supplementing with donor milk pasteurized by both methods. The purpose of this study is to compare the incidence of microbiological proven late onset sepsis in newborns under 1000 grams that in the first 28 days of life need to be supplemented with donor milk pasteurized by HTST method versus the Holder method. This is a randomized double-blind clinical trial with parallel assignment. A total of 305 premature babies with a birth weight of less than 1000 grams will be recruited, admitted to the Neonatology Services of the Hospital 12 de Octubre and the Hospital de La Paz and meet the inclusion criteria. Half of the patients will be supplemented exclusively with donor milk pasteurized by the HTST system and the other half with pasteurized milk by the Holder method. Linear generalized models will be used for longitudinal data analysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04424667
Study type Interventional
Source Hospital Universitario 12 de Octubre
Contact
Status Completed
Phase N/A
Start date June 15, 2020
Completion date September 15, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05530330 - Markers of Platelet Activation foR Identification of Late Onset Sepsis in Preterm Infants
Not yet recruiting NCT06199102 - The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants. N/A
Recruiting NCT04717037 - Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS) Phase 2/Phase 3
Completed NCT03299751 - Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates N/A
Not yet recruiting NCT06118801 - The Effect of Probiotics Added to the Mother's Diet on Preterm Babies N/A
Recruiting NCT04842786 - Topical Coconut Oil Application and Incidence of Sepsis in Neonates N/A
Completed NCT03822104 - Bovine Colostrum as a Human Milk Fortifier for Preterm Infants N/A
Recruiting NCT05981079 - Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis. Phase 4
Recruiting NCT05991648 - Effect of Kangaroo Care on Heart Rate Variability in Late-onset Neonatal Sepsis N/A
Completed NCT03085277 - Bovine Colostrum for Preterm Newborns N/A
Recruiting NCT05347238 - Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
Completed NCT04792918 - Characterization of Intestinal Microbiota Stability in Preterm Born Neonates
Recruiting NCT03997266 - NICU Antibiotics and Outcomes Trial Phase 4
Completed NCT03633500 - Effectiveness of Oral Immunotherapy Among Preterm Babies N/A